No Picture
News

Published Study Demonstrates Feasibility of a Blood Test to Predict Disease Progression and Metastasis in Localized Prostate Cancer

SAN DIEGO, May 30, 2019 /PRNewswire/ — Epic Sciences, Inc. announced today the publication of a six-year study demonstrating the clinical applicability of circulating tumor cells (CTCs) to predict prostate cancer progression and metastasis. The stu… […]

No Picture
News

When the World Comes to Life

Johnny Bear Contreras can recall with perfect clarity the moment the world came to life for him. He was working high atop the mountains in the ski town of Mammoth Lakes. For weeks, the sky had been heavy with cl… […]

No Picture
News

It Takes a Network

To raise a child with a fair shot at college, it takes more than a village—it takes a network. UC San Diego’s Center for Research on Educational Equity, Assessment and Teaching Excellence, or CREATE, has taken t… […]

No Picture
News

NuVasive SpineTRACK Registry Successfully Meets 2018 Medicare Reporting Requirements For Merit-based Incentive Payments System

SpineTRACK represents the only industry-sponsored spine registry that qualified providers to receive positive payment adjustments up to seven percent on all Medicare reimbursements in 2020

SAN DIEGO, May 30, 2019 /PRNewswire/ — NuVasive, Inc. (NASDA… […]

No Picture
News

Inhibrx Announces Option Agreement for Development and Commercialization of INBRX-101 (AAT-Fc) Outside of the United States and Canada with Chiesi Group

– Up to $162.5M in upfront, cost sharing and milestone payments, and escalating royalties into the high teens assuming exercise of the option

SAN DIEGO, May 30, 2019 /PRNewswire/ — Inhibrx, Inc. (“Inhibrx”), a clinical-stage biotechnology company de… […]